These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 19679339)

  • 21. Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract.
    Roscigno M; Cozzarini C; Bertini R; Scattoni V; Freschi M; Da Pozzo LF; Briganti A; Gallina A; Capitanio U; Colombo R; Giorgio G; Montorsi F; Rigatti P
    Eur Urol; 2008 Apr; 53(4):794-802. PubMed ID: 18207313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The oncological results of laparoscopic nephroureterectomy for upper urinary tract transitional cell cancer are equal to those of open nephroureterectomy.
    Waldert M; Remzi M; Klingler HC; Mueller L; Marberger M
    BJU Int; 2009 Jan; 103(1):66-70. PubMed ID: 18710438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract.
    Novara G; De Marco V; Dalpiaz O; Gottardo F; Bouygues V; Galfano A; Martignoni G; Patard JJ; Artibani W; Ficarra V
    BJU Int; 2008 Jun; 101(11):1368-74. PubMed ID: 18241252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper urinary tract.
    Nakanishi K; Tominaga S; Hiroi S; Kawai T; Aida S; Kasamatsu H; Aurues T; Hayashi T; Ikeda T
    Virchows Arch; 2002 Dec; 441(6):559-63. PubMed ID: 12461612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.
    Rouprêt M; Hupertan V; Traxer O; Loison G; Chartier-Kastler E; Conort P; Bitker MO; Gattegno B; Richard F; Cussenot O
    Urology; 2006 Jun; 67(6):1181-7. PubMed ID: 16765178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience.
    Rouprêt M; Hupertan V; Sanderson KM; Harmon JD; Cathelineau X; Barret E; Vallancien G; Rozet F
    Urology; 2007 Apr; 69(4):656-61. PubMed ID: 17445646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter.
    Kamijima S; Tobe T; Suyama T; Ueda T; Igarashi T; Ichikawa T; Ito H
    Int J Urol; 2005 Nov; 12(11):941-7. PubMed ID: 16351648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Large series of 114 cases with long-term follow-up of upper urinary tract urothelial tumors].
    Izquierdo L; Truán D; Alvarez-Vijande R; Alcaraz A
    Actas Urol Esp; 2010 Mar; 34(3):232-7. PubMed ID: 20416239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of Ki-67 and COX-2 in patients with upper urinary tract urothelial carcinoma.
    Jeon HG; Jeong IG; Bae J; Lee JW; Won JK; Paik JH; Kim HH; Lee SE; Lee E
    Urology; 2010 Aug; 76(2):513.e7-12. PubMed ID: 20573388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary urothelial carcinoma of the upper urinary tract in dialysis patients with 5-year follow-up.
    Kang CH; Chen CH; Chiang PH
    Jpn J Clin Oncol; 2010 Mar; 40(3):241-6. PubMed ID: 19933687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression profile of E-cadherin and N-cadherin in urothelial carcinoma of the upper urinary tract is associated with disease recurrence in patients undergoing nephroureterectomy.
    Muramaki M; Miyake H; Terakawa T; Kusuda Y; Fujisawa M
    Urology; 2011 Dec; 78(6):1443.e7-12. PubMed ID: 21924460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer.
    Akao J; Matsuyama H; Yamamoto Y; Hara T; Kawai Y; Sakano S; Ohmi C; Gondo T; Naito K
    BJU Int; 2008 Aug; 102(5):572-5. PubMed ID: 18485032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tract.
    Thompson RH; Krambeck AE; Lohse CM; Elliott DS; Patterson DE; Blute ML
    BJU Int; 2008 Nov; 102(9):1107-10. PubMed ID: 18522631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract.
    Kang CH; Yu TJ; Hsieh HH; Yang JW; Shu K; Huang CC; Chiang PH; Shiue YL
    Cancer; 2003 Oct; 98(8):1620-6. PubMed ID: 14534877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
    Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma.
    Wu CF; Chang PL; Chen CS; Chuang CK; Weng HH; Pang ST
    J Urol; 2006 Aug; 176(2):477-81. PubMed ID: 16813872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
    Soga N; Arima K; Sugimura Y
    Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Urothelial carcinoma of the upper urinary tract. Survival and prognostic factors].
    Arrizabalaga Moreno M; Díez Rodríguez JM; García González JI; Esteban Arteaga R; Navarro Sebastián J; Castro Pita M; Mora Durban M; Paniagua Andrés P
    Arch Esp Urol; 1998 Apr; 51(3):243-51. PubMed ID: 9622915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KI67 proliferation index in tumors of the upper urinary tract as related to established prognostic factors and long-term survival.
    Rey A; Lara PC; Redondo E; Valdés E; Apolinario R
    Arch Esp Urol; 1998 Mar; 51(2):204-10. PubMed ID: 9586325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Roscigno M; Shariat SF; Margulis V; Karakiewicz P; Remzi M; Kikuchi E; Langner C; Lotan Y; Weizer A; Bensalah K; Raman JD; Bolenz C; Guo CC; Wood CG; Zigeuner R; Wheat J; Kabbani W; Koppie TM; Ng CK; Suardi N; Bertini R; Fernández MI; Mikami S; Isida M; Michel MS; Montorsi F
    J Urol; 2009 Jun; 181(6):2482-9. PubMed ID: 19371878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.